ENTX
Entera Bio
$3.92
+$1.87 (+91.22%)Jul 27, 2026
Key metrics
The numbers that frame ENTX today
- Market cap
- $192.96M
- P/E (TTM)
- -15.6
- EV / FCF
- -19.8
- ROIC
- 2,570.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.91
- 52wk High
- $4.20
Growth
Revenue and earnings trend for ENTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ENTX
Is Entera Bio a good buy?
No. Entera Bio has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Entera Bio is selling at a high price.
What is the market capitalization of ENTX?
Entera Bio's market capitalization is $192.96M.
What is the P/E ratio for ENTX stock?
Entera Bio's current P/E ratio is -15.6.
What is the 52-week high for ENTX stock?
The 52-week high for Entera Bio is $4.20. The current close of $3.92 is 6.7% below that high.
What is the 52-week low for ENTX stock?
The 52-week low for Entera Bio is $0.91. The current close of $3.92 is 330.8% above that low.
Does ENTX stock pay dividends?
Entera Bio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ENTX?
Entera Bio's Debt / Equity ratio is 0.04.